Development of a low cost, rapid, high throughput Covid-19 assay for isolation/back to work decisions for key workers
- Funded by CSO Scotland
- Total publications:2 publications
Grant number: COV/SCL/20/04
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$203,885.76Funder
CSO ScotlandPrincipal Investigator
Damion CorriganResearch Location
United KingdomLead Research Institution
University of StrathclydeResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
COVID-19 is difficult to diagnose and contain because of the non-specific nature of the symptoms (asymptomatic to life threatening). To deal with the epidemic as quickly as possible and be in a position to manage a "second wave", it is necessary to introduce mass, repeatable testing for the benefit of those yet to be infected and ongoing serology testing to identify those already exposed. Our test will enable screening of workers, at low cost, in their place of work, identifying and isolating those with the disease and enabling recovered individuals to return to the workforce